Improving the understanding of how patients with non-dystrophic myotonia are selected for myotonia treatment with mexiletine (NaMuscla): outcomes of treatment impact using a Europe...

por Chapman, Ann-Marie, Schurer, Marieke, Weijers, Laure, Omar, Amer, Lee, Hiba, Weidenfeller, Alla Zozulya, Ellis, Crispin, Sonecha, Shaneil, Schneider-Gold, Christiane
Publicado 2021

Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada

por Weijers, Laure, Baerwald, Christoph, Mennini, Francesco S., Rodríguez-Heredia, José M., Bergman, Martin J., Choquette, Denis, Herrmann, Kirsten H., Attinà, Giulia, Nappi, Carmela, Merino, Silvia Jimenez, Patel, Chad, Mtibaa, Mondher, Foo, Jason
Publicado 2017